Susan Hasty, Publisher
Table of Contents . . . April 5th, 2000
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Vaccine Weekly | Other Publications
Malaria - MAP Vaccine Tested for Safety and Immunogenicity in Phase I Trial
Cancer Vaccines - Genetic Vaccination with Self Protein Eradicates Melanoma in a Murine Model
Cancer Vaccines - IL-2 Potentiates Immunologic Response of Dendritic-Cell-Based Tumor Vaccines
Cancer Vaccines - Interleukin-2 Enhances Therapeutic Anticancer Vaccines
Immunization - Childhood Vaccination Rates Affected by Several Factors
Influenza Vaccines - Intranasal Vaccine Safe, Efficacious
Pneumococcal Immunization - Vaccine Safe in Renal Transplant Recipients
Rubella - Testing for Specific Immunoglobulin G Antibody in Urine Possible
Cervical Cancer - HPV-E5 Protein Targeted by Peptide Vaccine
Hepatitis B Vaccines - Synthetic, Microencapsulated Peptide Vaccine Under Development
Malaria - Cellular Responses to T-Cell Epitopes Evaluated in Cameroon
Non-Hodgkin's Lymphoma - Phase II Clinical Trial for Oncophage Cancer Vaccine Announced
Chickenpox - Experts Want to See Improved Rates of Varicella Immunization
Funding - Phase I SBIR Grant for MHC Class II Enhanced Cancer Vaccines Announced
Industry News - Alliance Formed To Discover and Develop Therapeutic Monoclonal Antibodies
Industry News - New Vaccines Expected to Bolster Adult Immunization Sales
Pediatric Case Study - Valproate and Hepatitis C Virus Lead to Fatality
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.